Timothy grass pollen recombinant major allergen immunotherapy adsorbed onto aluminium hydroxide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Timothy grass pollen recombinant major allergen immunotherapy adsorbed onto aluminium hydroxide, covering 2013-11-08 to 2013-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma [Phase 3]